Ustekinumab-Aekn 51759-0710-32

Package NDC

51759-0710-32

Manufacturer: Teva Pharmaceuticals Usa, Inc.
Dosage Form: Injection, Solution
Route: Subcutaneous
Product Type: Human Prescription Drug
Marketing Start: June 2, 2025
Listing Expires: December 31, 2026
Application: BLA761343

Need to source Ustekinumab-Aekn? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Ustekinumab-Aekn	90 mg/mL

Drug Class

Interleukin-12 Antagonist [EPC]Interleukin-12 Antagonists [MoA]Interleukin-23 Antagonist [EPC]

Selected Package

51759-0710-32Selected

1 TRAY in 1 CARTON (51759-710-32) / 1 SYRINGE, GLASS in 1 TRAY / 1 mL in 1 SYRINGE, GLASS